<DOC>
	<DOCNO>NCT00271180</DOCNO>
	<brief_summary>The main purpose Product Performance Report ( formerly refer System Longevity Study ) evaluate long-term performance Medtronic market-released cardiac rhythm product analyze product survival probability .</brief_summary>
	<brief_title>Product Performance Report : Evaluate Long-term Reliability &amp; Performance Medtronic Marketed Cardiac Therapy Products</brief_title>
	<detailed_description>All Medtronic market-released lead market-released IPG , ICD CRT device eligible include study .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Tachycardia , Sinus</mesh_term>
	<criteria>Subjects meet follow inclusion criterion meet follow exclusion criterion eligible enrollment . â€¢ Subject appropriate legal guardian provide write informed consent and/or authorization access use health information require institution 's IRB/MEC/REB AND one following must also apply : Subject indicate implant within 30 day postimplant least one Medtronic marketreleased product use pacing , sense defibrillation application Subjects participate qualify study ( IDE ) Medtronic marketreleased product complete implant followup data subject appropriate legal guardian authorize release subject study data Subjects , inaccessible followup Subjects exclusion criterion require local law ( EMEA ) Subjects receive implant Medtronic device nonparticipating center implant data current status confirm within 30 day implant Subjects implant Medtronic device whose predetermined enrollment limit specific product exceed</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Cardiac Pacing</keyword>
	<keyword>Implantable Cardioverter Defibrillator</keyword>
	<keyword>pacemaker</keyword>
	<keyword>Sinus Bradycardia</keyword>
</DOC>